Price movement over the last 24 hours
Align Technology, Inc. vs abrdn Physical Palladium Shares ETF — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while abrdn Physical Palladium Shares ETF trades at $22.99. The key difference: Align Technology, Inc. is trading nearer its 52-week high, abrdn Physical Palladium Shares ETF nearer its low. Which is the better fit depends on your goals.
| ALGN | PALL | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $207.19 | $37.18 |
52-Week Low | $124.88 | $19.96 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
PALL (abrdn Physical Palladium Shares ETF) trades at $23.07, up 1.63% with bearish technical signals from moving averages but neutral oscillators. The ETF recently underwent a 5-for-1 stock split effective May 18, 2026. Financial ratios are unavailable, but palladium's 47% price decline from January 2026 highs has drawn attention as a potential catch-up trade amid broader precious metals strength.
The outlook hinges on palladium's supply-demand dynamics, with Seeking Alpha highlighting a buying opportunity at current levels due to industrial demand and supply risks. Key risks include Federal Reserve policy impacts and commodity volatility. Analyst sentiment is cautiously optimistic, viewing the price weakness as a potential entry point for exposure to palladium's recovery prospects.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.
Read more on PALL →